Efficacy News and Research

RSS
Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting

Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting

4 Aug 2011
Zalicus second quarter revenue decreases to $1.8 million

Zalicus second quarter revenue decreases to $1.8 million

3 Aug 2011
Narrative exposure therapy can reduce PTSD symptoms in former child soldiers

Narrative exposure therapy can reduce PTSD symptoms in former child soldiers

3 Aug 2011
ARIAD reports $47.8 million net loss for second quarter 2011

ARIAD reports $47.8 million net loss for second quarter 2011

2 Aug 2011
BARDA awards contracts for development of drugs for radiation injury to the GI tract

BARDA awards contracts for development of drugs for radiation injury to the GI tract

2 Aug 2011
FDA accepts MAP Pharmaceuticals' LEVADEX NDA for filing

FDA accepts MAP Pharmaceuticals' LEVADEX NDA for filing

2 Aug 2011
VP, balloon kyphoplasty safe and effective for women with vertebral fractures

VP, balloon kyphoplasty safe and effective for women with vertebral fractures

2 Aug 2011
Femta files IND with FDA for FM101 monoclonal antibody against RA

Femta files IND with FDA for FM101 monoclonal antibody against RA

1 Aug 2011
Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

1 Aug 2011
FDA should collect information needed to develop new framework for 510(k) clearance process

FDA should collect information needed to develop new framework for 510(k) clearance process

30 Jul 2011
SACHDNC presents new recommendations for storing dried newborn blood specimens

SACHDNC presents new recommendations for storing dried newborn blood specimens

30 Jul 2011
ORENCIA SC formulation receives FDA approval for treatment of adults with RA

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

30 Jul 2011
Anthera reports increase in second quarter total operating expenses to $22.7 million

Anthera reports increase in second quarter total operating expenses to $22.7 million

29 Jul 2011
Antioxidants may help treat infertility problems in both women and men

Antioxidants may help treat infertility problems in both women and men

29 Jul 2011
NIH selects Viamet's novel antifungal compound for inclusion in the TRND program

NIH selects Viamet's novel antifungal compound for inclusion in the TRND program

29 Jul 2011
FDA issues Refusal to File letter for Eisai's perampanel NDA to treat partial-onset seizures

FDA issues Refusal to File letter for Eisai's perampanel NDA to treat partial-onset seizures

29 Jul 2011
Scientist discovers novel way to convert human skin cells into neurons

Scientist discovers novel way to convert human skin cells into neurons

29 Jul 2011
RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

29 Jul 2011
Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

28 Jul 2011
All Canadian provinces except Quebec announce funding agreement for PNH drug, Soliris

All Canadian provinces except Quebec announce funding agreement for PNH drug, Soliris

28 Jul 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback